- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
NCQA Recognizes Priority Health Plans as Top Performers
The accolades just keep on coming for Grand Rapids, Michigan–based Priority Health, with this latest recognition from the National Committee for Quality Assurance (NCQA) goin to its top-performing Medicaid, Medicare, and commercial health plans.
Grand Rapids, Michigan — Earlier this month, the National Committee for Quality Assurance (NCQA) recognized Priority Health's portfolio of Medicaid, Medicare, and commmercial health plans as top performers. Priority's Medicare HMO/POS plan received 4.5 of 5 stars from the NCQA, while its commercial HMO/POS and PPO plans received 4 stars. The Medicaid plan, meanwhile, a high performer.
This latest recogntion follows similar accolades received over the past year, not only from CMS but also from Michigan. Earlier this year, CMS also was awarded Health Equity Accreditation status from the NCQA.
“Priority Health’s history of receiving national recognition for the quality of our health plans is a direct reflection of our commitment to ensure our members receive high-quality care and service,” said Praveen Thadani, president of Priority Health. “We are dedicated to our mission and vision of making health simple, affordable, equitable and exceptional. I’m so proud of our team for this great accomplishment.”
You can read more about this news right here.
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
